Axalta Merger Proxy Supplemented with AkzoNobel Q2 Results and Russian Asset Seizure
AXTA sits 32% above its 52-week low of $24.937.
Summary
Axalta's merger proxy is supplemented with AkzoNobel's Q2 2026 results, showing stable earnings but rising debt, a Russian asset seizure, and a large legal provision — key data for the August 5 shareholder vote.
Key Events · M&A and Partnerships · AXTA
-
AkzoNobel Q2 Results Disclosed
AkzoNobel reported Q2 2026 revenue of €2,589M (down 1% YoY), operating income €251M (up 17%), and adjusted EBITDA €398M (up 1%). Half-year net income was €232M, flat versus prior year.
-
Russian Entities Seized
A July 13 presidential decree placed AkzoNobel's Russian entities under temporary external administration. The company will deconsolidate them, resulting in a €214M net asset write-off and a €49M cumulative translation loss recycled to the income statement.
-
Legal Provision and Contingent Liability
AkzoNobel recognized a €300M provision for the Ichthys project legal case, with potential damages claimed up to AUD 4.8B (€2.9B). Insurance covers up to €500M of cash outflows.
-
Leverage Increases
Net debt rose to €3,127M from €2,942M at year-end 2025, driven by dividend payments and bond issuances. The leverage ratio increased to 2.2x from 2.0x.
Analysis · AXTA · Industrial Applications And Services
Axalta shareholders voting on the AkzoNobel merger on August 5 now have critical new data: AkzoNobel's Q2 results show stable earnings (adjusted EBITDA €398M, up 1%) but rising leverage (2.2x net debt/EBITDA) and a €214M Russian asset seizure that will trigger a €49M currency loss. The results also reveal a €300M provision for the Ichthys legal case, with potential damages up to €2.9B. These disclosures materially update the financial picture of the combined company and could influence the merger vote.
How filings like this one have moved
In the 30 days to Sep 15, 2026, 35.6% of the 1100 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.43%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, AXTA was trading at $32.80 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $7B. The 52-week trading range was $24.94 to $35.72. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.